Daunomycin and blood bilirubin increased Patient Reports February 11, 2012
Daunomycin Side Effects Report #4784467-5
Daunomycin side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 29, 2005. Male patient, weighting 205.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunomycin. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, asterixis, blood bilirubin increased, blood creatinine increased, bone marrow disorder, confusional state. Daunomycin dosage: unknown. During the same period patient was treated with CYTARABINE, MYLOTARG, GROWTH FACTOR. Patient was hospitalized. Patient died on 09/15/2005.
Daunomycin Side Effects Report #4642291-8
Daunomycin side effect was reported by a Consumer or non-health professional from on Apr 21, 2005. Male patient, weighting 174.6 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunomycin. After drug was administered, patient experienced the following side effects: atelectasis, blood bilirubin increased, blood culture positive, pleural effusion, streptococcal infection
. Daunomycin dosage: 60 MG/M2 IVP ON DAYS 1, 8, 15 AND 22. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, ELSPAR, METHOTREXATE. Patient recovered.Daunomycin Side Effects Report #4647207-6
Daunomycin side effect was reported by a Consumer or non-health professional from on Apr 26, 2005. Male patient, weighting 174.6 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunomycin. After drug was administered, patient experienced the following side effects: atelectasis, blood bilirubin increased, pleural effusion, streptococcal sepsis. Daunomycin dosage: 60 MG/M2 IVP ON DAYS 1, 8,15 AND 22.. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient recovered.
Daunomycin Side Effects Report #4697893-X
Daunomycin side effect was reported by a Consumer or non-health professional from on June 21, 2005. Male patient, weighting 151.2 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunomycin. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood fibrinogen decreased, chest pain
, coagulopathy, dizziness
. Daunomycin dosage: 60 MG/M2 IVP ON DAYS 1, 8, 15, AND 22. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient recovered.Daunomycin Side Effects Report #4724655-7
Daunomycin side effect was reported by a Consumer or non-health professional from UNITED STATES on July 19, 2005. Male patient, weighting 174.6 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunomycin. After drug was administered, patient experienced the following side effects: atelectasis, bacterial infection
, blood bilirubin increased, pleural effusion, sepsis
, streptococcal infection
. Daunomycin dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.Daunomycin Side Effects Report #4647762-6
Daunomycin side effect was reported by a Consumer or non-health professional from on Apr 27, 2005. Male patient, weighting 174.6 lb, was treated with Daunomycin. After drug was administered, patient experienced the following side effects: atelectasis, bacterial infection
, blood bilirubin increased, blood culture positive, pleural effusion, streptococcal sepsis. Daunomycin dosage: 60MG/M2 IVP ON DAYS 1,8,15,AND 22. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.Daunomycin Side Effects Report #4664353-1
Daunomycin side effect was reported by a Consumer or non-health professional from on May 16, 2005. Male patient, weighting 174.6 lb, was treated with Daunomycin. After drug was administered, patient experienced the following side effects: atelectasis, bacterial sepsis, blood bilirubin increased, pleural effusion. Daunomycin dosage: 60MG/M2 IVP ON DAYS 1,8,15,AND 22. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.
Daunomycin and blood bilirubin increased 